Markedly enhanced levodopa pharmacokinetics from continuous subcutaneous carbidopa administration

被引：0
|
作者：
Yacoby-Zeevi, O. [1 ]
Oren, S. [1 ]
LeWitt, P. [2 ,3 ]
机构：
[1] NeuroDerm Ltd, Ness Ziona, Israel
[2] Wayne State Univ, Sch Med, Southfield, MI USA
[3] Henry Ford Hosp, Southfield, MI USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [1] Administration of continuous subcutaneous carbidopa improves levodopa pharmacokinetics
    Yacoby-Zeevi, O.
    Oren, S.
    LeWitt, P.
    MOVEMENT DISORDERS, 2011, 26 : S284 - S284
  • [2] Continuous Administration of Subcutaneous Levodopa/Carbidopa (ND0612) Demonstrated Comparable Levodopa Pharmacokinetics to Levodopa/Carbidopa Intestinal Gel (LCIG)
    Adar, Liat
    Minei, Tamar Rachmilewitz
    Cohen, Yael
    Oren, Sheila
    NEUROLOGY, 2017, 88
  • [3] Continuous Subcutaneous Administration of Carbidopa Enhances Levodopa Pharmacokinetics: A Series of Studies Conducted in the Pig, Mouse and Healthy Volunteers
    Yacoby-Zeevi, Oron
    Zawoznik, Eduardo
    Weinstock, Irena
    Nemas, Mara
    Caraco, Yossi
    LeWitt, Peter
    Oren, Sheila
    Shaltiel-Karyo, Ronit
    NEUROLOGY, 2016, 86
  • [4] Continuous subcutaneous carbidopa improves levodopa pharmacokinetics in Parkinson's disease patients
    Caraco, Y.
    Giladi, N.
    Oren, S.
    LeWitt, P. A.
    MOVEMENT DISORDERS, 2012, 27 : S111 - S111
  • [5] POPULATION PHARMACOKINETICS OF LEVODOPA AND CARBIDOPA FOLLOWING SUBCUTANEOUS INFUSION
    Birnberg, T.
    Adar, L.
    Smania, G.
    Bjornsson, M.
    Jonsson, N.
    Case, R.
    Karlsson, M. O.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 47 - 47
  • [6] PHARMACOKINETICS OF CONTINUOUS-RELEASE CARBIDOPA/LEVODOPA
    SAGE, JI
    MARK, MH
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 : S1 - S6
  • [7] The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
    LeWitt, Peter A.
    Stocchi, Fabrizio
    Arkadir, David
    Caraco, Yoseph
    Adar, Liat
    Perlstein, Itay
    Case, Ryan
    Giladi, Nir
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [8] PHARMACOKINETICS OF LEVODOPA AND CARBIDOPA IN RATS FOLLOWING DIFFERENT ROUTES OF ADMINISTRATION
    BREDBERG, E
    LENNERNAS, H
    PAALZOW, L
    PHARMACEUTICAL RESEARCH, 1994, 11 (04) : 549 - 555
  • [9] Levodopa Pharmacokinetics in Switching From Levodopa/Carbidopa Intestinal Gel to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion in a Patient With Parkinson's Disease: A Case Report
    Nukariya, Tomonori
    Tezuka, Toshiki
    Okusa, Shohei
    Okochi, Ryotaro
    Sakai, Yuto
    Nihei, Yoshihiro
    Nakahara, Jin
    Seki, Morinobu
    JOURNAL OF MOVEMENT DISORDERS, 2025,
  • [10] Subcutaneous Administration of Carbidopa Enhances Oral Levodopa Pharmacokinetics: A Series of Studies Conducted in Pigs, Mice, and Healthy Volunteers
    Shaltiel-Karyo, Ronit
    Caraco, Yoseph
    Zawaznik, Eduardo
    Weinstock, Irena
    Nemas, Mara
    Oren, Sheila
    Yacoby-Zeevi, Oron
    LeWitt, Peter A.
    CLINICAL NEUROPHARMACOLOGY, 2019, 42 (04) : 111 - 116
12345